Vir Biotechnology, Inc.

Verified identity

Start with the filing record

The identity and ticker come from the SEC’s official company ticker mapping. Market and editorial coverage are not inferred from that record.

Market price

TickerGrove coverage

Deals

Unlike Vir's April deal with Astellas, this one covers drugs that have not been designed yet, aimed at targets the companies have not named.

Published 10-17-2026 · Vir Biotechnology, Inc.

Research foundation

Company analysis

Revenue is the top-line amount recognized from a company’s activities under its accounting policy.

Company analysis

The income statement records revenue and expenses over a period.

Investing basics

A stock is an ownership interest in one company.